American Clinical Solutions LLC

American Clinical Solutions LLC was paid $3.77M by Medicaid between Jan 2018 and Nov 2024, across 48 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 7.7% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#18 of 225

Median peer was paid$74K

This provider vs. median51×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	88,820	$1.32M
2019	122,185	$1.48M
2020	35,371	$246K
2021	28,003	$266K
2022	31,515	$336K
2023	11,201	$104K
2024incomplete	1,553	$20K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	7.7%	9,905	8,204	$290K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.2%	5,543	4,742	$196K
80325		4.7%	9,764	7,511	$176K
80345		3.8%	11,147	8,772	$143K
83992		3.2%	10,999	8,649	$122K
80356		3.0%	11,404	8,984	$114K
80346		3.0%	11,144	8,786	$114K
80367		3.0%	11,179	8,801	$113K
80372		3.0%	11,163	8,795	$113K
80373		3.0%	11,178	8,806	$113K
80361		3.0%	11,463	9,038	$113K
80365		3.0%	11,487	9,060	$113K

36 more codes

80368		3.0%	11,135	$113K
80348		3.0%	11,212	$113K
80357		3.0%	11,179	$113K
80366		3.0%	11,131	$112K
80354		3.0%	11,236	$112K
80358		3.0%	11,231	$111K
80360		2.9%	11,036	$111K
80353		2.9%	11,209	$111K
80359		2.9%	11,173	$110K
80370		2.6%	9,690	$99K
80364		2.6%	9,690	$98K
80349		2.5%	9,496	$96K
80355		2.5%	8,254	$95K
80334		2.3%	4,738	$85K
80323		1.8%	4,471	$66K
80338		1.7%	4,976	$63K
80371		1.7%	5,219	$62K
80339		1.6%	4,609	$60K
80337		1.6%	4,749	$59K
80344		1.4%	4,048	$54K
80321		1.4%	3,632	$53K
80352		1.4%	4,147	$52K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	336	$27K
80362		<1%	1,182	$14K
80369		<1%	1,146	$13K
80324		<1%	1,194	$13K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,452	$7K
82570		<1%	6,022	$7K
80335		<1%	395	$5K
80350		<1%	388	$4K
80332		<1%	390	$4K
80342		<1%	390	$4K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	947	$3K
80347		<1%	16	$201.40
80363		<1%	137	$184.49
80326		<1%	16	$182.05

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROWN, ROGER (PRESIDENT)

Same official

Other billing entities under BROWN, ROGER

Full network →

Provider	Location	Paid
The Center for Adhd, INC	Mandeville, LA	$326K
Sunstate Physicians LLC	Boca Raton, FL	$77K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.